Experts say acquiring these pounds-loss drugs as a result of alternate routes could be risky, due to the fact neither Novo nor Eli Lilly market their drugs to other suppliers.BOSTON — Clinicians at inside medicine and endocrinology meetings not too long ago introduced circumstance studies describing pancreatitis in individuals taking tirzepatide.